Murray CJL. The worldwide burden of illness research at 30 years. Nat Med. 2022;28:2019–26.
Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Coronary heart illness and stroke statistics-2023 replace: a report from the American coronary heart affiliation. Circulation. 2023;147:e93-621.
Kléber AG, Rudy Y. Fundamental mechanisms of cardiac impulse propagation and related arrhythmias. Physiol Rev. 2004;84:431–88.
Kovacs B, Mayinger M, Andratschke N, Saguner AM. Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation? Eur Coronary heart J. 2022;43:3279–81.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 yr traits in atrial fibrillation prevalence, incidence, danger components, and mortality within the Framingham coronary heart research: a cohort research. Lancet Lond Engl. 2015;386:154–62.
Murakoshi N, Aonuma Ok. Epidemiology of arrhythmias and sudden cardiac loss of life in Asia. Circ J. 2013;77:2419–31.
Zhang X, Gao Y, Zhou Y, Liu Z, Liu R. Pharmacological mechanism of pure medicine and their energetic substances within the remedy of arrhythmia through calcium channel regulation. Biomed Pharmacother. 2023;160:114413.
Monteiro LM, Vasques-Nóvoa F, Ferreira L, Pinto-do-Ó P, Nascimento DS. Restoring coronary heart perform and electrical integrity: closing the circuit. Npj Regen Med. 2017;2:9.
Clauss S, Bleyer C, Schüttler D, Tomsits P, Renner S, Klymiuk N, et al. Animal fashions of arrhythmia: basic electrophysiology to genetically modified massive animals. Nat Rev Cardiol. 2019;16:457–75.
Chun Ok-RJ, Miklavčič D, Vlachos Ok, Bordignon S, Scherr D, Jais P, et al. State-of-the-art pulsed subject ablation for cardiac arrhythmias: ongoing evolution and future perspective. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Teams Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2024;26:134.
Maron BJ, Estes NAM, Rowin EJ, Maron MS, Reynolds MR. Growth of the implantable cardioverter-defibrillator: JACC historic breakthroughs in perspective. J Am Coll Cardiol. 2023;82:353–73.
Gaur N, Ortega F, Verkerk AO, Mengarelli I, Krogh-Madsen T, Christini DJ, et al. Validation of quantitative measure of repolarization reserve as a novel marker of drug induced proarrhythmia. J Mol Cell Cardiol. 2020;145:122–32.
Wang Tao, Li W, Huang Q, Yuan C, Qu L, Xiao X, et al. The scientific efficacy and security of 11 generally used remedy methods bettering arrhythmia of CHD in China: a community meta-analysis. Entrance Pharmacol. 2021;12:741716.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC pointers for the analysis and remedy of acute and power coronary heart failure. Eur Coronary heart J. 2021;42:3599–726.
Bordignon S, Chun KRJ, Gunawardene M, Fuernkranz A, City V, Schulte-Hahn B, et al. Comparability of balloon catheter ablation applied sciences for pulmonary vein isolation: the laser versus cryo research. J Cardiovasc Electrophysiol. 2013;24:987–94.
Kuck Ok-H, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KRJ, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.
Duytschaever M, De Potter T, Grimaldi M, Anic A, Vijgen J, Neuzil P, et al. Paroxysmal atrial fibrillation ablation utilizing a novel variable-loop biphasic pulsed subject ablation catheter built-in with a third-dimensional mapping system: 1-year outcomes of the multicenter inspIRE research. Circ Arrhythm Electrophysiol. 2023. https://doi.org/10.1161/CIRCEP.122.011780.
Furnkranz A, Bordignon S, Schmidt B, Perrotta L, Dugo D, De Lazzari M, et al. Incidence and traits of phrenic nerve palsy following pulmonary vein isolation with the second-generation as in contrast with the first-generation cryoballoon in 360 consecutive sufferers. Europace. 2015;17:574–8.
Bordignon S, My I, Tohoku S, Rillig A, Schaack D, Chen S, et al. Efficacy and security in sufferers handled with a novel radiofrequency balloon: a two centres expertise from the AURORA collaboration. Europace. 2023;25:106.
Boersma L, Andrade JG, Betts T, Duytschaever M, Pürerfellner H, Santoro F, et al. Progress in atrial fibrillation ablation throughout 25 years of Europace journal. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Teams Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2023;25:244.
Sawatari H, Ohkusa T, Rahamawati A, Ishikawa Ok, Tsuchihashi-Makaya M, Ohtsuka Y, et al. 35Article: left ventricular ejection fraction predicts severity of posttraumatic stress dysfunction in sufferers with implantable cardioverter-defibrillators. Clin Cardiol. 2016;39:263–8.
Kajanová A, Bulava A, Eisenberger M. 36Article: components influencing psychological standing and high quality of life in sufferers with implantable cardioverter-defibrillators. Neuro Endocrinol Lett. 2014;35(Suppl 1):54–8.
Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, et al. Various purposes of nanomedicine. ACS Nano. 2017;11:2313–81.
Radomska A, Leszczyszyn J, Radomski MW. The nanopharmacology and nanotoxicology of nanomaterials: new alternatives and challenges. Adv Clin Exp Med Off Organ Wroclaw Med Univ. 2016;25:151–62.
Varró A, Tomek J, Nagy N, Virág L, Passini E, Rodriguez B, et al. Cardiac transmembrane ion channels and motion potentials: mobile physiology and arrhythmogenic habits. Physiol Rev. 2021;101:1083–176.
Bers DM. Excitation-contraction coupling and cardiac contractile drive. Dordrecht: Springer; 2001.
Patel SP, Campbell DL. Transient outward potassium present, ‘Ito’, phenotypes within the mammalian left ventricle: underlying molecular, mobile and biophysical mechanisms. J Physiol. 2005;569:7–39.
Carol Ann R. Attending to the guts of rhythm: a century of progress. Physiol Rev. 2022;102:1553–67.
Grune J, Yamazoe M, Nahrendorf M. Electroimmunology and cardiac arrhythmia. Nat Rev Cardiol. 2021;18:547–64.
Jansen JA, van Veen TAB, de Bakker JMT, van Rijen HVM. Cardiac connexins and impulse propagation. J Mol Cell Cardiol. 2010;48:76–82.
Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct hole junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol. 1994;24:1124–32.
Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of hole junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;80:9–19.
Kanter HL, Laing JG, Beau SL, Beyer EC, Saffitz JE. Distinct patterns of connexin expression in canine Purkinje fibers and ventricular muscle. Circ Res. 1993;72:1124–31.
Gourdie RG, Severs NJ, Inexperienced CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to practical properties of elements of the cardiac atrioventricular conduction system. J Cell Sci. 1993;105(Pt 4):985–91.
Temple IP, Inada S, Dobrzynski H, Boyett MR. Connexins and the atrioventricular node. Coronary heart Rhythm. 2013;10:297–304.
Veenstra RD, Wang HZ, Westphale EM, Beyer EC. A number of connexins confer distinct regulatory and conductance properties of hole junctions in growing coronary heart. Circ Res. 1992;71:1277–83.
Davis LM, Rodefeld ME, Inexperienced Ok, Beyer EC, Saffitz JE. Hole junction protein phenotypes of the human coronary heart and conduction system. J Cardiovasc Electrophysiol. 1995;6:813–22.
Hegyi B, Bossuyt J, Griffiths LG, Shimkunas R, Coulibaly Z, Jian Z, et al. Complicated electrophysiological transforming in postinfarction ischemic coronary heart failure. Proc Natl Acad Sci USA. 2018;115:E3036–44.
Sinno H, Derakhchan Ok, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in canines. Circulation. 2003;107:1930–6.
Rivard L, Sinno H, Shiroshita-Takeshita A, Schram G, Leung T-Ok, Nattel S. The pharmacological response of ischemia-related atrial fibrillation in canines: proof for substrate-specific efficacy. Cardiovasc Res. 2007;74:104–13.
Nishida Ok, Qi XY, Wakili R, Comtois P, Chartier D, Harada M, et al. Mechanisms of atrial tachyarrhythmias related to coronary artery occlusion in a power canine mannequin. Circulation. 2011;123:137–46.
Tk Ok, Ir E. Mechanisms of fibrillation: neurogenic or myogenic? Reentrant or focal? A number of or single? Nonetheless puzzling after 160 years of inquiry. J Cardiovasc Electrophysiol. 2010. https://doi.org/10.1111/j.1540-8167.2010.01820.x.
Nattel S. New concepts about atrial fibrillation 50 years on. Nature. 2002;415:219–26.
Jalife J. Ventricular fibrillation: mechanisms of initiation and upkeep. Annu Rev Physiol. 2000;62:25–50.
Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Latest advances within the molecular pathophysiology of atrial fibrillation. J Clin Make investments. 2011;121:2955–68.
Bossu A, Houtman MJC, Meijborg VMF, Varkevisser R, Beekman HDM, Dunnink A, et al. Selective late sodium present inhibitor GS-458967 suppresses Torsades de pointes by largely affecting perpetuation however not initiation of the arrhythmia. Br J Pharmacol. 2018;175:2470–82.
Liu W, Kim TY, Huang X, Liu MB, Koren G, Choi B-R, et al. Mechanisms linking T-wave alternans to spontaneous initiation of ventricular arrhythmias in rabbit fashions of lengthy QT syndrome. J Physiol. 2018;596:1341–55.
Rhee J-W, Wu JC. Advances in nanotechnology for the administration of coronary artery illness. Traits Cardiovasc Med. 2013;23:39–45.
Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer analysis. Int J Nanomed. 2012;7:4391–408.
Wang AZ, Langer R, Farokhzad OC. Nanoparticle supply of most cancers medicine. Annu Rev Med. 2012;63:185–98.
Soumya RS, Raghu KG. Latest advances on nanoparticle-based therapies for cardiovascular ailments. J Cardiol. 2023;81:10–8.
Jiang W, Ming Xu, Qin Mu, Zhang D, Shaohui Wu, Liu Xu, et al. Research on the function and mechanism of lncRNA within the transforming of atrial power metabolism in rabbits with atrial fibrillation primarily based on nano sensor know-how. Bioengineered. 2022;13:863–75.
Nadimi AE, Yousef Ebrahimipour S, Afshar EG, Falahati-Pour SK, Ahmadi Z, Mohammadinejad R, et al. Nano-scale drug supply programs for antiarrhythmic brokers. Eur J Med Chem. 2018;157:1153–63.
Wang Z, Tong Qi, Li T, Qian Y. Nano medicine supply system: a novel promise for the remedy of atrial fibrillation. Entrance Cardiovasc Med. 2022;9:906350.
Jalilinejad N, Rabiee M, Baheiraei N, Ghahremanzadeh R, Salarian R, Rabiee N, et al. Electrically conductive carbon-based (bio)-nanomaterials for cardiac tissue engineering. Bioeng Transl Med. 2023;8:e10347.
Bakola V, Karagkiozaki V, Tsiapla AR, Pappa F, Moutsios I, Pavlidou E, et al. Dipyridamole-loaded biodegradable PLA nanoplatforms as coatings for cardiovascular stents. Nanotechnology. 2018;29:275101.
Amin DR, Sink E, Narayan SP, Abdel-Hafiz M, Mestroni L, Peña B. Nanomaterials for cardiac tissue engineering. Mol Basel Switz. 2020;25:5189.
Nguyen AH, Marsh P, Schmiess-Heine L, Burke PJ, Lee A, Lee J, et al. Cardiac tissue engineering: state-of-the-art strategies and outlook. J Biol Eng. 2019;13:57.
Fleischer S, Feiner R, Dvir T. 40Review: cutting-edge platforms in cardiac tissue engineering. Curr Opin Biotechnol. 2017;47:23–9.
Haq AU, Carotenuto F, Di Nardo P, Francini R, Prosposito P, Pescosolido F, et al. Extrinsically conductive nanomaterials for cardiac tissue engineering purposes. Micromachines. 2021;12:914.
Ahmad Z, Shah A, Siddiq M, Kraatz H-B. Polymeric micelles as drug supply automobiles. RSC Adv. 2014;4:17028–38.
Roche ET, Hastings CL, Lewin SA, Shvartsman DE, Brudno Y, Vasilyev NV, et al. Comparability of biomaterial supply automobiles for bettering acute retention of stem cells within the infarcted coronary heart. Biomaterials. 2014;35:6850–8.
Crampton HL, Simanek EE. Dendrimers as drug supply automobiles: non-covalent interactions of bioactive compounds with dendrimers. Polym Int. 2007;56:489–96.
Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical supply purposes. Chem Soc Rev. 2012;41:2545–61.
Wilczewska AZ, Niemirowicz Ok, Markiewicz KH, Automotive H. Nanoparticles as drug supply programs. Pharmacol Rep PR. 2012;64:1020–37.
Zhang RX, Li J, Zhang T, Amini MA, He C, Lu B, et al. Significance of integrating nanotechnology with pharmacology and physiology for revolutionary drug supply and remedy—an illustration with firsthand examples. Acta Pharmacol Sin. 2018;39:825–44.
Bayford R, Rademacher T, Roitt I, Wang SX. Rising purposes of nanotechnology for analysis and remedy of illness: a evaluate. Physiol Meas. 2017;38:R183-203.
Rizvi SAA, Saleh AM. Functions of nanoparticle programs in drug supply know-how. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2018;26:64–70.
Martinez-Hernandez E, Blatter LA. Impact of carvedilol on atrial excitation-contraction coupling, Ca2+ launch, and arrhythmogenicity. Am J Physiol Coronary heart Circ Physiol. 2020;318:H1245–55.
Penttilä T, Mäkynen H, Hartikainen J, Hyppölä H, Lauri T, Lehto M, et al. Antiarrhythmic drug remedy amongst sufferers presenting to emergency division with symptomatic atrial fibrillation—a potential nationwide cohort. Scand J Trauma Resusc Emerg Med. 2017;25:81.
Arzani G, Haeri A, Daeihamed M, Bakhtiari-Kaboutaraki H, Dadashzadeh S. Niosomal carriers improve oral bioavailability of carvedilol: results of bile salt-enriched vesicles and provider floor cost. Int J Nanomed. 2015;10:4797–813.
Shah MK, Madan P, Lin S. Elucidation of intestinal absorption mechanism of carvedilol-loaded stable lipid nanoparticles utilizing Caco-2 cell line as an in-vitro mannequin. Pharm Dev Technol. 2015;20:877–85.
Aboud HM, El Komy MH, Ali AA, El Menshawe SF, Elbary AAbd. Growth, optimization, and analysis of carvedilol-loaded stable lipid nanoparticles for intranasal drug supply. AAPS PharmSciTech. 2016;17:1353–65.
Srinivasarao M, Low PS. Ligand-targeted drug supply. Chem Rev. 2017;117:12133–64.
Sergeevichev DS, Krasilnikova AA, Strelnikov AG, Fomenko VV, Salakhutdinov NF, Romanov AB, et al. Globular chitosan prolongs the efficient length time and reduces the acute toxicity of botulinum neurotoxin after intramuscular injection in rats. Toxicon. 2018;143:90–5.
Hamilton D, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, et al. Amiodarone: a complete information for clinicians. Am J Cardiovasc Medication. 2020;20:549–58.
Pokorney SD, Holmes DN, Shrader P, Thomas L, Fonarow GC, Mahaffey KW, et al. Patterns of amiodarone use and outcomes in scientific follow for atrial fibrillation. Am Coronary heart J. 2020;220:145–54.
Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based evaluate of scientific indications. JAMA. 2007;298:1312.
Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Acute amiodarone pulmonary toxicity. J Cardiothorac Vasc Anesth. 2021;35:1485–94.
Goundan PN, Lee SL. Thyroid results of amiodarone: scientific replace. Curr Opin Endocrinol Diabetes Obes. 2020;27:329–34.
Ruzieh M, Moroi MK, Aboujamous NM, Ghahramani M, Naccarelli GV, Mandrola J, et al. Meta-analysis evaluating the relative danger of antagonistic occasions for amiodarone versus placebo. Am J Cardiol. 2019;124:1889–93.
Motawea A, Ahmed DAM, Eladl AS, El-Mansy AAEl-R, Saleh NM. Appraisal of amiodarone-loaded PLGA nanoparticles for potential security and toxicity in a rat mannequin. Life Sci. 2021;274:119344.
Motawea A, Ahmed DAM, El-Mansy AA, Saleh NM. Essential function of PLGA nanoparticles in mitigating the amiodarone-induced pulmonary toxicity. Int J Nanomed. 2021;16:4713–37.
Liu Y, Lingling X, Zhang Q, Kang Y, Liu L, Liu Z, et al. Localized myocardial anti-inflammatory results of temperature-sensitive budesonide nanoparticles throughout radiofrequency catheter ablation. Analysis. 2022. https://doi.org/10.3413/2022/9816234.
Lilei Yu, Scherlag BS, Dormer Ok, Rutel I, Huang B, Zhou X, et al. Focused ganglionated plexi denervation utilizing magnetic nanoparticles carrying calcium chloride payload. JACC Clin Electrophysiol. 2018;4:1347–58.
Zhuge Y, Zheng Z-F, Xie M-Q, Li L, Wang F, Gao F. Preparation of liposomal amiodarone and investigation of its cardiomyocyte-targeting skill in cardiac radiofrequency ablation rat mannequin. Int J Nanomed. 2016;11:2359–67.
Propranolol. Lancet Lond Engl. 1967;1:939–40.
Al-Kassas R, Wen J, Cheng AE-M, Kim AM-J, Liu SSM, Yu J. Transdermal supply of propranolol hydrochloride by way of chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr Polym. 2016;153:176–86.
Han J, Zhang Y, Wang X, Zhang G, Yu Z, Wang C, et al. Ultrasound-mediated piezoelectric nanoparticle modulation of intrinsic cardiac autonomic nervous system for charge management in atrial fibrillation. Biomater Sci. 2023;11:655–65.
Sagini Ok, Buratta S, Delo F, Pellegrino RM, Giovagnoli S, Urbanelli L, Emiliani C. Drug-induced lysosomal impairment is related to the discharge of extracellular vesicles carrying autophagy markers. Int J Mol Sci. 2021;22(23):12922.
O’Quinn MP, Dormer KJ, Huizar JF, Nguyen KT, Kaszala Ok, Sima A, et al. Epicardial injection of nanoformulated calcium into cardiac ganglionic plexi suppresses autonomic nerve exercise and postoperative atrial fibrillation. Coronary heart Rhythm. 2019;16:597–605.
Shen MJ. The cardiac autonomic nervous system: an introduction. Herzschrittmachertherapie Elektrophysiologie. 2021;32:295–301.
Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY. Interplay of mitochondrial calcium and ROS in neurodegeneration. Cells. 2022;11:706.
Lilei Yu, Scherlag BJ, Dormer Ok, Nguyen KT, Pope C, Fung Ok-M, et al. Autonomic denervation with magnetic nanoparticles. Circulation. 2010;122:2653–9.
Jiang W, Ming Xu, Qin Mu, Zhang D, Shaohui Wu, Liu Xu, et al. Position and mechanism of lncRNA beneath magnetic nanoparticles in atrial autonomic nerve transforming throughout radiofrequency ablation of recurrent atrial fibrillation. Bioengineered. 2022;13:4173–84.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.
Ashtari Ok, Nazari H, Ko H, Tebon P, Akhshik M, Akbari M, et al. Electrically conductive nanomaterials for cardiac tissue engineering. Adv Drug Deliv Rev. 2019;144:162–79.
Murry CE, Robb MacLellan W. Stem cells and the heart-the highway forward. Science. 2020;367:854–5.
Esmaeili H, Patino-Guerrero A, Hasany M, Ansari MO, Memic A, Dolatshahi-Pirouz A, et al. Electroconductive biomaterials for cardiac tissue engineering. Acta Biomater. 2022;139:118–40.
Hasan A, Morshed M, Memic A, Hassan S, Webster TJ, Marei HE-S. Nanoparticles in tissue engineering: purposes, challenges and prospects. Int J Nanomed. 2018;13:5637–55.
Holt E, Lunde PK, Sejersted OM, Christensen G. Electrical stimulation of grownup rat cardiomyocytes in tradition improves contractile properties and is related to altered calcium dealing with. Fundamental Res Cardiol. 1997;92:289–98.
Crowder SW, Liang Y, Rath R, Park AM, Maltais S, Pintauro PN, et al. Poly(ε-caprolactone)–carbon nanotube composite scaffolds for enhanced cardiac differentiation of human mesenchymal stem cells. Nanomed. 2013;8:1763–76.
Gorain B, Choudhury H, Pandey M, Kesharwani P, Abeer MM, Tekade RK, et al. Carbon nanotube scaffolds as rising nanoplatform for myocardial tissue regeneration: a evaluate of latest developments and therapeutic implications. Biomed Pharmacother Biomedecine Pharmacother. 2018;104:496–508.
Alamdari SG, Alibakhshi A, de la Guardia M, Baradaran B, Mohammadzadeh R, Amini M, et al. Conductive and semiconductive nanocomposite-based hydrogels for cardiac tissue engineering. Adv Healthc Mater. 2022;11:2200526.
Saberi A, Jabbari F, Zarrintaj P, Saeb MR, Mozafari M. Electrically conductive supplies: alternatives and challenges in tissue engineering. Biomolecules. 2019;9:448.
Dong R, Ma PX, Guo B. Conductive biomaterials for muscle tissue engineering. Biomaterials. 2020;229:119584.
Shin SR, Jung SM, Zalabany M, Kim Ok, Zorlutuna P, Kim SB, et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano. 2013;7:2369–80.
Kim S-C, Whitten J, Kumar J, Bruno FF, Samuelson LA. Self-doped carboxylated polyaniline: impact of hydrogen bonding on the doping of polymers. Macromol Res. 2009;17:631–7.
Zhang C, Hsieh M-H, Tune-Yi Wu, Li S-H, Jun Wu, Liu S-M, et al. A self-doping conductive polymer hydrogel that may restore electrical impulse propagation at myocardial infarct to forestall cardiac arrhythmia and protect ventricular perform. Biomaterials. 2020;231:119672.
Roshanbinfar Ok, Vogt L, Greber B, Diecke S, Boccaccini AR, Scheibel T, et al. Electroconductive biohybrid hydrogel for enhanced maturation and beating properties of engineered cardiac tissues. Adv Funct Mater. 2018;28:1803951.
Roshanbinfar Ok, Mohammadi Z, Mesgar AS-M, Dehghan MM, Oommen OP, Hilborn J, et al. Carbon nanotube doped pericardial matrix derived electroconductive biohybrid hydrogel for cardiac tissue engineering. Biomater Sci. 2019;7:3906–17.
Smith AST, Yoo H, Yi H, Ahn EH, Lee JH, Shao G, et al. Micro- and nano-patterned conductive graphene-PEG hybrid scaffolds for cardiac tissue engineering. Chem Commun Camb Engl. 2017;53:7412–5.
Liu Y, Jinfu Lu, Guisen Xu, Wei J, Zhang Z, Li X. Tuning the conductivity and internal construction of electrospun fibers to advertise cardiomyocyte elongation and synchronous beating. Mater Sci Eng C. 2016;69:865–74.
Shevach M, Fleischer S, Shapira A, Dvir T. Gold nanoparticle-decellularized matrix hybrids for cardiac tissue engineering. Nano Lett. 2014;14:5792–6.
Yu H, Zhao H, Huang C, Du Y. Mechanically and electrically enhanced CNT-collagen hydrogels as potential scaffolds for engineered cardiac constructs. ACS Biomater Sci Eng. 2017;3:3017–21.
Dong R, Pang Y, Su Y, Zhu X. Supramolecular hydrogels: synthesis, properties and their biomedical purposes. Biomater Sci. 2015;3:937–54.
Eng G, Lee BW, Protas L, Gagliardi M, Brown Ok, Kass RS, et al. Autonomous beating charge adaptation in human stem cell-derived cardiomyocytes. Nat Commun. 2016;7:10312.
Solar Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res. 2000;46:250–6.
Vunjak Novakovic G, Eschenhagen T, Mummery C. Myocardial tissue engineering: in vitro fashions. Chilly Spring Harb Perspect Med. 2014;4:a014076.
Menasché P, Hagège AA, Vilquin J-T, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for extreme postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1078–83.
Li Y, Wei L, Lan L, Gao Y, Zhang Q, Dawit H, et al. Conductive biomaterials for cardiac restore: a evaluate. Acta Biomater. 2022;139:157–78.
Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and performance of bioengineered cardiac grafts. Circulation. 1999;100:II63-69.
Zimmermann W-H, Melnychenko I, Wasmeier G, Didié M, Naito H, Nixdorff U, et al. 91Article: engineered coronary heart tissue grafts enhance systolic and diastolic perform in infarcted rat hearts. Nat Med. 2006;12:452–8.
Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe Ok, et al. Fabrication of pulsatile cardiac tissue grafts utilizing a novel third-dimensional cell sheet manipulation approach and temperature-responsive cell tradition surfaces. Circ Res. 2002;90:e40.
Zimmermann W-H, Didié M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, et al. Cardiac grafting of engineered coronary heart tissue in syngenic rats. Circulation. 2002;106:I151-157.
Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al. Bioengineered cardiac grafts: a brand new strategy to restore the infarcted myocardium? Circulation. 2000;102:III56-61.
Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka Ok, Hao H, et al. Monolayered mesenchymal stem cells restore scarred myocardium after myocardial infarction. Nat Med. 2006;12:459–65.
Kawamura M, Miyagawa S, Miki Ok, Saito A, Fukushima S, Higuchi T, et al. Feasibility, security, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy mannequin. Circulation. 2012;126:S29-37.
Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, Landa N, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic end result. Proc Natl Acad Sci USA. 2009;106:14990–5.
Bursac N, Lavatory Y, Leong Ok, Tung L. Novel anisotropic engineered cardiac tissues: research {of electrical} propagation. Biochem Biophys Res Commun. 2007;361:847–53.
Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol. 2011;6:720–5.
Xing M. Nanotechnology and nanomaterials for cardiac restore. In: Li R-Ok, Weisel RD, editors. Card regen restore. Sawston: Woodhead Publishing; 2014. p. 3–16.
He S, Tune H, Wu J, Li S-H, Weisel RD, Sung H-W, et al. Preservation of conductive propagation after surgical restore of cardiac defects with a bio-engineered conductive patch. J Coronary heart Lung Transplant. 2018;37:912–24.
Chen S, Hsieh M-H, Li S-H, Jun Wu, Weisel RD, Chang Y, et al. a conductive cell-delivery assemble as a bioengineered patch that may enhance electrical propagation and synchronize cardiomyocyte contraction for coronary heart restore. J Management Launch Off J Management Launch Soc. 2020;320:73–82.
Balint R, Cassidy NJ, Cartmell SH. Conductive polymers: in direction of a wise biomaterial for tissue engineering. Acta Biomater. 2014;10:2341–53.
Liau B, Zhang D, Bursac N. Useful cardiac tissue engineering. Regen Med. 2012;7:187–206.
Mawad D, Mansfield C, Lauto A, Perbellini F, Nelson GW, Tonkin J, et al. A conducting polymer with enhanced digital stability utilized in cardiac fashions. Sci Adv. 2016;2:e1601007.
Pedrotty DM, Kuzmenko V, Karabulut E, Sugrue AM, Livia C, Vaidya VR, et al. Three-dimensional printed biopatches with conductive ink facilitate cardiac conduction when utilized to disrupted myocardium. Circ Arrhythm Electrophysiol. 2019;12:e006920.
Zhao G, Feng Y, Xue L, Cui M, Zhang Q, Xu F, et al. Anisotropic conductive lowered graphene oxide/silk matrices promote post-infarction myocardial perform by restoring electrical integrity. Acta Biomater. 2022;139:190–203.
Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, Martens TP, et al. Challenges in cardiac tissue engineering. Tissue Eng Half B Rev. 2010;16:169–87.
Au HTH, Cheng I, Chowdhury MF, Radisic M. Interactive results of floor topography and pulsatile electrical subject stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials. 2007;28:4277–93.
Maidhof R, Tandon N, Lee EJ, Luo J, Duan Y, Yeager Ok, et al. Biomimetic perfusion and electrical stimulation utilized in live performance improved the meeting of engineered cardiac tissue. J Tissue Eng Regen Med. 2012;6:e12-23.
Guan J, Wang F, Li Z, Chen J, Guo X, Liao J, et al. The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium construction and biomechanics. Biomaterials. 2011;32:5568–80.
Ahadian S, Khademhosseini A. Sensible scaffolds in tissue regeneration. Regen Biomater. 2018;5:125–8.
Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, et al. Nanowired three dimensional cardiac patches. Nat Nanotechnol. 2011;6:720–5.
Ren J, Xu Q, Chen X, Li W, Guo Ok, Zhao Y, et al. Superaligned carbon nanotubes information oriented cell development and promote electrophysiological homogeneity for artificial cardiac tissues. Adv Mater. 2017;29:1702713.
Pok S, Vitale F, Eichmann SL, Benavides OM, Pasquali M, Jacot JG. Biocompatible carbon nanotube-chitosan scaffold matching {the electrical} conductivity of the guts. ACS Nano. 2014;8:9822–32.
Mahshid Kharaziha S, Shin R, Nikkhah M, Topkaya SN, Masoumi N, Annabi N, et al. Robust and versatile CNT-polymeric hybrid scaffolds for engineering cardiac constructs. Biomaterials. 2014;35:7346–54.
Ahadian S, Davenport Huyer L, Estili M, Yee B, Smith N, Xu Z, et al. Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac tissue engineering. Acta Biomater. 2017;52:81–91.
Cho S, Discher DE, Leong KW, Vunjak-Novakovic G, Joseph CWu. Challenges and alternatives for the subsequent era of cardiovascular tissue engineering. Nat Strategies. 2022;19:1064–71.
Malima A, Siavoshi S, Musacchio T, Upponi J, Yilmaz C, Somu S, et al. Extremely delicate microscale in vivo sensor enabled by electrophoretic meeting of nanoparticles for a number of biomarker detection. Lab Chip. 2012;12:4748–54.
Polymers in biosensor units for cardiovascular purposes. Curr Opin Biomed Eng. 2020;13:69–75
Latest progress on the delicate detection of heart problems markers by electrochemical-based biosensors. J Pharm Biomed Anal. 2018;159:406–24.
Feiner R, Engel L, Fleischer S, Malki M, Gal I, Shapira A, et al. Engineered hybrid cardiac patches with multifunctional electronics for on-line monitoring and regulation of tissue perform. Nat Mater. 2016;15:679–85.
Lei Y-M, Xiao M-M, Li Y-T, Xu L, Zhang H, Zhang Z-Y, et al. Detection of coronary heart failure-related biomarker in entire blood with graphene subject impact transistor biosensor. Biosens Bioelectron. 2017;91:1–7.
Malhotra N, Lee J-S, Liman RAD, Ruallo JMS, Villaflores OB, Ger T-R, et al. Potential toxicity of iron oxide magnetic nanoparticles: a evaluate. Mol Basel Switz. 2020;25:3159.
Wu T, Tang M. Assessment of the consequences of manufactured nanoparticles on mammalian goal organs. J Appl Toxicol JAT. 2018;38:25–40.
Zhang Y-N, Poon W, Tavares AJ, McGilvray ID, Chan WCW. Nanoparticle–liver interactions: mobile uptake and hepatobiliary elimination. J Management Launch. 2016;240:332–48.
Boey A, Ho HK. All roads result in the liver: steel nanoparticles and their implications for liver well being. Small Weinh Bergstr Ger. 2020;16:e2000153.
Bostan HB, Rezaee R, Valokala MG, Tsarouhas Ok, Golokhvast Ok, Tsatsakis AM, et al. Cardiotoxicity of nano-particles. Life Sci. 2016;165:91–9.
Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, et al. Gold nanoparticles of diameter 1.4 nm set off necrosis by oxidative stress and mitochondrial harm. Small Weinh Bergstr Ger. 2009;5:2067–76.
Park J, Kim B, Han J, Oh J, Park S, Ryu S, et al. Graphene oxide flakes as a mobile adhesive: prevention of reactive oxygen species mediated loss of life of implanted cells for cardiac restore. ACS Nano. 2015;9:4987–99.
Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Artificial nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like capabilities. Nat Nanotechnol. 2013;8:61–8.
Hussain Z, Thu HE, Elsayed I, Abourehab MAS, Khan S, Sohail M, et al. Nano-scaled supplies might induce extreme neurotoxicity upon power publicity to mind tissues: a crucial appraisal and up to date updates on predisposing components, underlying mechanism, and future prospects. J Management Launch Off J Management Launch Soc. 2020;328:873–94.
Foulkes R, Man E, Thind J, Yeung S, Pleasure A, Hoskins C. The regulation of nanomaterials and nanomedicines for scientific utility: present and future views. Biomater Sci. 2020;8:4653–64.
Wu G, Li P, Feng H, Zhang X, Chu PK. Engineering and functionalization of biomaterials through floor modification. J Mater Chem B. 2015;3:2024–42.
Carnovale C, Bryant G, Shukla R, Bansal V. Measurement, form and floor chemistry of nano-gold dictate its mobile interactions, uptake and toxicity. Prog Mater Sci. 2016;83:152–90.
Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a technique for bettering nanoparticle-based drug and gene supply. Adv Drug Deliv Rev. 2016;99:28–51.
Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS. Stealth coating of nanoparticles in drug-delivery programs. Nanomaterials. 2020;10:787.
Kedmi R, Veiga N, Ramishetti S, Goldsmith M, Rosenblum D, Dammes N, et al. A modular platform for focused RNAi therapeutics. Nat Nanotechnol. 2018;13:214–9.
Anne G. Early Consciousness and Motion System for Superior Supplies (Early4AdMa): Pre-regulatory and anticipatory danger governance device to Superior Supplies.
Peláez EC, Estevez M-C, Portela A, Salvador J-P, Marco M-P, Lechuga LM. Nanoplasmonic biosensor system for the monitoring of acenocoumarol therapeutic drug in plasma. Biosens Bioelectron. 2018;119:149–55.
Lin Z, Kireev D, Liu N, Gupta S, LaPiano J, Obaid SN, et al. Graphene biointerface for cardiac arrhythmia analysis and remedy. Adv Mater Deerfield Seaside Fla. 2023;35:e2212190.
Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene remedy. Nat Rev Genet. 2020;21:255–72.
Nguyen HX, Wu T, Wants D, Zhang H, Perelli RM, DeLuca S, et al. Engineered bacterial voltage-gated sodium channel platform for cardiac gene remedy. Nat Commun. 2022;13:620.